Guideline for Advertising of e-cigarettes

Similar documents
Bill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

Introduction. Principles

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

MARKETING STANDARDS FOR MEMBERSHIP

Policy Options for the Regulation of Electronic Cigarettes

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

Policy Options for the Regulation of Electronic Cigarettes

E-cigarette reforms. Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017

Electronic/E-cigarettes. In summary

Policy Options for the Regulation of Electronic Cigarettes

Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products

DRAFT FOR CONSULTATION

How to Regulate E-Cigarettes? Are we asking the right questions?

Text 1: E-Cigarettes, the solution or another risk factor?

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

The New Zealand experience with electronic cigarettes

Problem Which option Additional option Additional comments definition Yes No change No further observations.

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

Survey to Measure the Effectiveness of Electronic Cigarettes - October 2012

Coach on Call. Thank you for your interest in E-Cigarettes: Your Questions Answered. I hope you find this tip sheet helpful.

Global E-Cigarette Market- Industry Analysis & Outlook ( )

Consultation on Electronic Cigarettes. Analysis of submissions

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

TOBACCO PRODUCT OR MEDICAL PRODUCT?

Therapeutic Advertising Pre-Vetting System (TAPS)

Prevent disease Protect from injury Promote healthy lifestyles

Tobacco Control Seminar Series 2014

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

Smoke Free Policy Practice Guidance Note Guidance on the use of E-Cigarettes by Service Users, Staff and Visitors - V02

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

12 Vaping Stats & Trends for the Informed E-Cig Retailer

Discussion points on Bill S-5

E-Cigs, Etc.: Policy Options for Regulating Nicotine Delivery Devices. Indiana Local Boards of Health Webinar Feb. 12, 2015

The Latest on Vaping Among U.S. Teens

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)

Guideline on the Regulation of Therapeutic Products in New Zealand

Electronic Nicotine and Non Nicotine Delivery Systems (ENDS)

A GUIDE TO NEW REGULATIONS NICOTINE VAPOUR PRODUCT AND TOBACCO COMPLIANCE IN SCOTLAND

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Young adults and e-cigarettes: a qualitative exploration of awareness, experience and attitudes

ACHIEVING SMOKEFREE AOTEAROA BY2025

First Amendment Issues in Advertising and Product Packaging

Using Stop Smoking Medicines

Towards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England

E-Cigarettes & Vaping. Information for Women & Their Families

Melodie Tilson, Director of Policy

The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

In Confidence. Office of the Associate Minister Health. Chair, Social Policy Committee. Regulation of smokeless tobacco and nicotine-delivery products

e-cigarette Regulation

ACS Submission: Consultation on the advertising of electronic cigarettes

How to change the legal classification of a medicine in New Zealand

TGA: the current regulatory reform agenda

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Evaluating Interventions to Curb ENDS Use Among Utah Youth

Helping Smokers to Quit in General Practice

Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes

Vape to break the smoking habit

Young people and e-cigarettes in Scotland

Overview Consumer Health Products Law and Compliance Issues

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

Policy Options for the Regulation of Electronic Cigarettes

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

CAMPUS SMOKING POLICY

BMA calls for strong regulation of e-cigarettes

SMOKE - FREE ONTARIO. The Next Chapter For a Healthier Ontario

Re: Policy Options for the Regulation of Electronic Cigarettes

TOBACCO FREE CAMPUS POLICY

G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S

Do Electronic Cigarettes Have Any Potential for Smoking Cessation? Professor Chris Bullen MBChB, MPH, PhD SRNT Webinar December 8th 2016

Use of electronic cigarettes (vapourisers) among adults in Great Britain

V2 NOTEBOOK-CIG AND/OR V2 POWER-CIG

15 Electronic Cigarettes Update

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

Smokefree Wiltshire. Information leaflet. Planning to quit? Find the right support for you.

Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

Electronic Cigarettes and the Medical Society

Be Tobacco-Wise. Learn about the benefits of quitting smoking. Reasons to be Smoke-Free

Key findings from a national survey of 1,000 registered voters, conducted February 2-5, Project # 15054

JUUL and Other Emerging Tobacco Products. Emily McClelland, M.S. December 6, 2018

Progress toward quitting. The cessation environment in New York

Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland

Pilot Testing Data Collection Instruments Janine Johal and Walid Sherif

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014

Operator s Manual Index NOTE:

National & International Developments in Tobacco Control Legislation

E-Cigs & Your Health. Made With Real Juice. by Ian Devine tdsmoke.com

Lily 说明书 尺寸 56*118mm 封面 250G白卡白珠光 烫银 内页 128g双铜纸四色印刷 装订方式 胶装 Tas i, L i! Lily 说明书

AA Response: CAP consultation on the advertising of electronic cigarettes

Kiewit Building Group 12/31/2013 Volume 2 Week 1

AN UPDATE ON FDA S COMPREHENSIVE PLAN ON TOBACCO AND NICOTINE

Smoking Cessation: A readily modifiable risk factor

Country profile. Myanmar

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I

Transcription:

GUIDELINE 43 Guideline for Advertising of e-cigarettes Last Updated May 2015 What kind of product is this guideline for? What is the purpose of this guideline? Electronic, or e-cigarettes, are battery powered devices which heat a liquid in them to produce a vapour, simulating smoke. Some contain nicotine, whilst others do not. They may or may not be supplied with cartridges. To provide guidance on the advertising compliance requirements for a range of products that are classed as e-cigarettes. BACKGROUND: The compliance requirements for the advertising of e-cigarettes are governed by the Medicines Act 1981, the Medicines Regulations 1984 (updated August 2011), the Medsafe Guideline on the Categorisation of Electronic Cigarettes ( The Medsafe Guideline ) and the Advertising Standards Authority (ASA) Therapeutic Products Advertising Code & the Code of Ethics. Before an e-cigarette is advertised, the advertiser should consult the Medsafe Guideline on the Categorisation of Electronic Cigarettes. This will ensure that the advertiser can determine if the e- cigarette can be advertised or sold and the kinds of claims the advertisement may contain. Please see appendix I of this document for the Medsafe Guideline A smoking cessation claim (or similar) in an advertisement for an e-cigarette is a therapeutic claim as defined in the Medicines Act. Only Medicines that have consent for distribution from the Minister of Health or Medical Devices that are listed on the Medsafe WAND (Wed Assisted Notification Database) can claim a therapeutic purpose in advertisements. The following are examples from the Medsafe Guideline of therapeutic purpose claims that relate to e-cigarettes; Supports or aid smoking cessation Remedy against/ helps alleviate nicotine addiction or the symptoms of nicotine addiction Helps you quit smoking/ smoke less Reduce your nicotine intake

Advertising Guidance for e-cigarettes by PRODUCT TYPE This Guideline is structured so that you can first determine which of the categories (A D) your product fits into and then you can follow the guidance in the category for advertising your product. Product Type A: E-cigarettes supplied for use as an aid to smoking cessation and one or more cartridges are supplied with the e-cigarette. OR; Product Type B: E-cigarettes supplied with one or more cartridges containing nicotine even if they are not represented as aids to smoking cessation. THESE PRODUCTS ARE MEDICINES You cannot sell, give away or advertise this product unless it has been evaluated by Medsafe and consent for distribution has been granted by the Minister of Health (via the NZ gazette). You would breach section 20 (2) of the Medicines Act if you were to do so. Once consent for distribution has been obtained, you must comply with the advertising requirements of the Medicines Act, the Medicines Regulations, the Medsafe Guideline on the Regulation of Therapeutic Products in New Zealand, Part 7: Advertising of Therapeutic Products and the ASA Therapeutic Products Advertising Code. The following TAPS Guidelines provide guidance on advertising compliance for medicines; TAPS Guideline 33: Checklist for Advertising OTC Medicines Directly to the Consumer TAPS Guideline 35 (A) and (B): Checklist for Advertising Prescription Medicines to Healthcare Professionals TAPS Guideline 36: Checklist for Advertising Prescription Medicines Directly to the Consumer TAPS Guideline 38 (A) and (B): Checklist for Advertising OTC Medicines to Healthcare Practitioners Product Type C: E-cigarettes supplied for use as an aid to smoking cessation and without cartridges THIS PRODUCT IS A MEDICAL DEVICE You cannot sell, give away or advertise this product unless it has been listed on the Medsafe WAND database (Web Assisted Notification Database). To find out more about WAND go to the Medsafe website http://www.medsafe.govt.nz/regulatory/devicesnew/3wand.asp Once the product is listed on the WAND database, you must comply with the advertising requirements of the Medicines Act, the Medicines Regulations, the Medsafe Guideline on the Regulation of Therapeutic Products in New Zealand, Part 7: Advertising of Therapeutic Products and the ASA Therapeutic Products Advertising Code. The Medsafe Guideline Page 10 provides easy to understand language on the legislated requirements for advertising a Medical Device and can be accessed through this link http://www.medsafe.govt.nz/regulatory/current-guidelines.asp

Claims in an advertisement for an e-cigarette that is listed on the WAND must be consistent with the intended purpose noted on the WAND form. Please Note: TAPS Adjudicators (or members of the public) are not able to access the WAND database. In order for TAPS to review an advertisement for an e-cigarette that is a Medical Device, the WAND listing form should be forwarded to the Adjudicator along with the proposed advertisement. Medical Devices are not evaluated by a regulatory body prior to listing on the WAND nor is consent required prior to distribution. This means that the onus for proof / substantiation of claims made about a medical device lies with the advertiser. This is covered in the evidence of conformity assessment on the WAND application form. If the advertisers claims to aid in smoking cessation for an e-cigarette that is a Medical Device listed on WAND, then the advertiser must have evidence to support this claim. The evidence must be readily available should the advertiser be required to substantiate a claim. Product Type D: E-cigarettes are a "gadget" when supplied to consumers who may choose to use them as a social prop or as an item which is to be used interchangeably with cigarettes. These gadgets must not contain nicotine or have cartridges that contain nicotine. Claims in advertisement must not be for a therapeutic purpose (e.g. to aid smoking cessation). Under the Smoke Free Legislation, these gadgets may only be sold to persons over the age of 18. THESE PRODUCTS ARE NOT MEDICINES OR MEDICAL DEVICES. THEY ARE CONSIDERED TO BE GADGETS. The advertising of these products should be socially responsible. The ASA Code of Ethics will be the main bench-mark for the compliance of advertisements for these products http://www.asa.co.nz/code_ethics.php. In order for advertisers of e-cigarettes in this category to meet the due standard of social responsibility in the development of such advertisements, TAPS recommends the following; Advertisements should be targeted at current cigarette smokers and not encourage nonsmokers to try the e-cigarettes. Advertisements should include the e-cigarette ingredients so that consumers are able to determine what they will be inhaling. Advertisements should make it clear that these products are e-cigarettes and cannot be mistaken for cigarettes (e.g. use of images or logos that make the products appear to be cigarettes or to be like a cigarette brand). Advertisements for e-cigarettes must not invoke tobacco brand identity. Advertisements should not have particular appeal to persons under the age of 18. Ideally, advertisements should not feature people who are, or who appear to be, under the age of 25. Advertisements for e-cigarettes should not claim that the product has health benefits or claim that it is safer or healthier than smoking tobacco. Advertisements should not glamorise smoking by showing people, for example, enjoying the e- cigarette or people being socially successful because they are using the e-cigarette. Advertisements should not attempt in any way to align with smoking cessation campaigns. The following are examples of the kinds of claims that may be suitable in advertisements for these products; An alternative to cigarettes / alternative to tobacco / alternative to smoking

Try this alternative way to smoke Keep yourself and your hands busy with this e-cigarette Inhale the flavoured vapour Enjoy the vapour flavours Reduce the cost of smoking cigarettes by using this product (only if the e-cigarette gadget costs less than the usual retail price of a cigarette) There should be a statement on all advertisements for these products, words to the effect; May only be sold to persons 18 years of age and over.

APPENDIX I The following guidance is provided by Medsafe and can be found on the Medsafe website at http://www.medsafe.govt.nz/regulatory/guideline/electroniccigarettes.asp. This guidance should be read and followed prior to the advertising of any e-cigarette products or devices. Medicines Categorisation of Electronic Cigarettes Revised: 5 November 2010 An electronic cigarette (e-cig) comprises a battery powered cigarette-shaped body with a mouthpiece or "cartridge" holding an absorbent material that is saturated with a flavoured liquid solution that may contain nicotine. E-cigs are commonly sold with a fitted cartridge but are also supplied as a battery powered vapourising unit to which a cartridge of choice can be fitted at a later time. The categorisation of an e-cig product depends on how it is presented for sale, including the intended use claimed for the product by the supplier and whether this use has a therapeutic purpose as defined in the Medicines Act 1981. Electronic cigarettes are medicines when they are supplied for use as an aid to smoking cessation and with one or more cartridges. Electronic cigarettes are medicines when supplied with one or more cartridges containing nicotine even if they are not represented as aids to smoking cessation. Electronic cigarettes are medical devices when they are supplied for use as an aid to smoking cessation and without cartridges. Electronic cigarettes are not therapeutic products when they are supplied as a "gadget" which consumers may choose to use as a social prop or as an item which is to be used interchangeably with cigarettes.

The following table provides further guidance on "intended purpose" language or claims that will be regarded as suggestive of a therapeutic purpose. Therapeutic purpose Supports or aids smoking cessation Remedy against/ helps alleviate nicotine addiction or the symptoms of nicotine addiction Helps you quit smoking/ smoke less Reduce your nicotine intake